Inventor · disambiguated record
Joon-Tae Park
Also filed as: PARK JOON TAE
5 granted patents·8 pending applications·12 citations·filing 2011–2023
71Inventor score
Files withILDONG PHARMACEUTICAL CO LTD7ILDONG PHARM CO LTD2IDIENCE CO LTD1INU RES & BUSINESS FOUNDATION1KANG JAE-HOON1
Top patents by PatentIndex Score
13 records- 0189US9844550B2Phtalazinone derivatives and manufacturing process thereofILDONG PHARM CO LTD·Filed 2017·Granted Dec 19, 2017·6 cites·9 claims
- 0287US9682973B2Phtalazinone derivatives and manufacturing process thereofILDONG PHARM CO LTD·Filed 2014·Granted Jun 20, 2017·6 cites·7 claims
- 0366US2023373954A1Novel acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0463US11767311B2Acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 26, 2023·0 cites·9 claims
- 0562USRE49338EPhthalazinone derivatives and manufacturing process thereofIDIENCE CO LTD·Filed 2014·Granted Dec 20, 2022·0 cites·39 claims
- 0658US2025214968A1Novel Salt of GLP-1 Receptor Agonist Compound, Preparation Method Thereof and Pharmaceutical Composition Comprising ThereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0758US2025042872A1Novel salt of 1-sulfonyl pyrrole derivative, method for preparing same, and pharmaceutical composition including sameILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0858US2025084026A1Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical composition comprising thereofILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0957US2025388582A1Novel bicyclic heteroaryl compound and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1055US12427143B2Pharmaceutical composition for treating or preventing aging or age-related diseasesINU RES & BUSINESS FOUNDATION·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 1155US2024366579A1Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitorILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1243US2023203554A1Process for reducing unwanted culture byproducts in cell culture mediumSAMSUNG BIOEPIS CO LTD·Filed 2017·Application pending·0 cites
- 1332US2012309750A15-membered heterocycle derivatives and manufacturing process thereofKANG JAE-HOON·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →